New CONSORT reporting guidelines published today in five medical journals
15 April 2025
The CONSORT 2025 statement, an updated guideline for reporting randomised trials is being simultaneously published in The BMJ, JAMA, The Lancet, Nature Medicine, and PLOS Medicine.
Blood cancer patients should continue treatment at time of COVID-19 vaccination, OCTRU study shows
9 April 2025
Evidence shows for patients with a type of leukaemia, pausing BTKi therapy for COVID-19 vaccination does not improve antibody responses to the vaccine
TRANSLATE Study Main Results Published
1 April 2025
Results paper published from the TRANSLATE study
SCT's 2025 Class of Fellows announced
28 March 2025
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals. This week the SCT 2025 Class of Fellows was announced and one of OCTRUs current interim directors - Professor Jonathan Cook was listed in that Class - A great accolade. Jonathan will be presented with his award during the SCT 2025 Annual Meeting in Vancouver in May.
SITU announces a trio of new trials
18 June 2024
SITU-NDORMS has announced the launch of three major new clinical trials. Funded by the NIHR, these studies are providing evidence for the treatment of chronic low back pain, knee osteoarthritis, and ACL injuries.
Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study
14 December 2023
A major clinical trial, led by the University of Nottigham and managed by the Oxford Clinical trials Research Unit (OCTRU), has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.